Mai Capital Management Exact Sciences Corp Transaction History

Mai Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $162,037 - $225,019	-2,235 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $29,237 - $40,192	324 Added 16.95%	2,235 $213,000
Q2 2021 Jul 19, 2021	BUY	$93.66 - $139.27 $1,030 - $1,531	11 Added 0.58%	1,911 $238,000
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $221,483 - $294,519	1,900 New	1,900 $250,000
Q4 2018 Jan 30, 2019	SELL	$56.04 - $82.66 $84,060 - $123,990	-1,500 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$48.29 - $80.6 $72,435 - $120,899	1,500 New	1,500 $118,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.